Biocardia's director, Stertzer, has made a significant investment by purchasing $498,000 worth of shares in the company. This move not only reflects his confidence in Biocardia's future but also signals to investors that the company is on a promising path. Such insider buying can often boost market sentiment and attract further investment, making it an important development for stakeholders.

Biocardia's director, Blank, has made a significant investment by purchasing $360,000 worth of common stock. This move not only reflects Blank's confidence in the company's future but also signals to investors that there is potential for growth. Such insider buying can often boost market sentiment and attract further investment, making it an important development for Biocardia and its stakeholders.